In my practice, I find myself combining therapies to enhance brain health, vision, and recovery from injuries.  Presently I’m using advanced photobiomodulation (PBM) and brainwave entrainment technologies. I integrate Lumiceuticals, TrueRife, and Seqex devices, all programmable with (biocompatable) gamma settings, to deliver a holistic treatment package.  I envision it as a “MED BED” of the future. This blog explores how these technologies, particularly with 40 Hz gamma entrainment, may support Alzheimer’s management, prevent or reverse retinopathy/macular degeneration, and aid recovery from brain, spine, and extremity injuries.

What is Photobiomodulation (PBM)?

Photobiomodulation uses low-level light, typically in the red or near-infrared spectrum, to stimulate cellular function. By enhancing mitochondrial activity, reducing inflammation, and promoting tissue repair, PBM supports healing across various conditions. In our practice, we leverage Lumiceuticals, TrueRife, and Seqex devices, which offer customizable frequencies, including 40 Hz gamma settings, to target brain health, vision, and injury recovery without the discomfort of traditional flickering light.

The Power of 40 Hz Gamma Entrainment

Gamma oscillations (30-100 Hz, often around 40 Hz) are rhythmic brain activities linked to memory, attention, and perception. Disrupted gamma activity is a hallmark of Alzheimer’s disease (AD), contributing to cognitive decline. Inducing 40 Hz gamma entrainment through sensory stimulation, such as light or electromagnetic fields, can synchronize neural activity, potentially reducing amyloid plaques and improving cognition, as shown in studies like Iaccarino et al. (Nature, 2016) and Martorell et al. (Cell, 2019).

From: https://www.frontiersin.org/journals/aging-neuroscience/articles/10.3389/fnagi.2017.00243/full

Traditional 40 Hz light therapy often uses stroboscopic light, which can cause visual discomfort and reduce patient adherence. Carstensen et al. (2020) introduced Invisible Spectral Flicker (ISF), a flicker-free technology using LEDs to modulate light at 40 Hz, improving comfort while maintaining efficacy. Our devices—Lumiceuticals, TrueRife, and Seqex—go further by delivering gamma entrainment through non-irritating light and electromagnetic pulses, making them ideal for long-term use.

From: Mystery of gamma wave stimulation in brain disorders

Our Comprehensive “MED BED” Approach

We’ve developed a unique treatment package combining Lumiceuticals, TrueRife, and Seqex devices, all programmable for gamma entrainment, to address a range of conditions. This “MED BED” concept integrates advanced technology to support brain health, vision, and recovery, offering a futuristic, non-invasive solution for patients of all ages. 

Lumiceuticals: Versatile Light Therapy

Lumiceuticals devices deliver pulsed light with over 9999 frequency options, including 40 Hz, and are FDA-cleared for pain relief and circulation enhancement. Their harmonic resonance technology enhances cellular energy, making them suitable for brain health and vision support. While not marketed for Alzheimer’s or retinopathy, their flexibility allows off-label exploration under medical supervision.

TrueRife: Targeted Frequency Delivery

TrueRife devices use electromagnetic frequencies, including gamma settings, to synchronize brainwave patterns. The TrueFocus system delivers light and sound with scalar energy for brainwave entrainment, supporting focus, memory, and recovery from brain injuries. TrueRife’s programmability ensures precise 40 Hz delivery without flicker, offering a comfortable alternative for Alzheimer’s and injury management.

Seqex: Electromagnetic Healing

Seqex devices generate pulsed electromagnetic fields (PEMFs) with customizable frequencies, including 40 Hz, to stimulate cellular repair and reduce inflammation. Seqex can also be personalized usin direct biofeedback to provide optimum energy transfer.  Used in Europe for decades, Seqex supports brain health, vision, and injury recovery by enhancing microcirculation and neural synchronization. Its non-invasive approach complements our “MED BED” package.

Applications in Alzheimer’s Disease

Our integrated approach targets Alzheimer’s pathology through gamma entrainment and cellular repair. Research highlights:

• Amyloid Reduction: 40 Hz stimulation reduces amyloid plaques in mouse models (Nature, 2016; Cell, 2019).

• Cognitive Improvement: Auditory and visual 40 Hz stimulation enhances memory (Cell, 2019).

• Neuroprotection: Chronic gamma entrainment preserves neurons and synapses (Neuron, Adaikkan et al., 2019).

• Microglia Activation: Gamma entrainment boosts amyloid clearance by microglia (Nature, 2016).

Lumiceuticals, TrueRife, and Seqex deliver 40 Hz gamma entrainment without flicker, improving patient comfort and adherence. While human trials, like the ALZLIGHT study, are ongoing, our practice offers this therapy off-label for patients with mild-to-moderate AD or mild cognitive impairment (MCI), under medical supervision.

Preventing and Reversing Retinopathy/Macular Degeneration

Age-related macular degeneration (AMD) and diabetic retinopathy are leading causes of vision loss, driven by oxidative stress and inflammation. PBM has shown promise in protecting retinal cells and improving visual function. Our devices deliver targeted light and electromagnetic frequencies to:

• Enhance retinal mitochondrial function.

• Reduce inflammation and oxidative damage.

• Promote blood flow to the retina.

Consistent use of Lumiceuticals, TrueRife, and Seqex, programmed with gamma and other therapeutic frequencies, may prevent progression and potentially reverse early-stage AMD and retinopathy. While clinical evidence is emerging, our patients report improved visual clarity with regular therapy.

Supporting Recovery from Brain, Spine, and Extremity Injuries

For younger patients with traumatic brain injuries (TBIs), spinal cord injuries, or extremity trauma, our “MED BED” approach accelerates healing. PBM and PEMF therapies:

• Reduce inflammation and edema.

• Stimulate neural repair and regeneration.

• Enhance blood flow to injured tissues.

TrueRife and Seqex devices, with gamma entrainment settings, support cognitive recovery in TBIs by synchronizing brain activity. Lumiceuticals’ light therapy aids tissue repair in spinal and extremity injuries. Case studies in our practice show improved motor function and cognitive outcomes with consistent use.

Why Choose This Combined Approach?

The “MED BED” package combines the strengths of Lumiceuticals, TrueRife, and Seqex for a comprehensive, non-invasive solution. Key benefits:

• Customizable Frequencies: All devices offer 40 Hz gamma settings and thousands of other frequencies for personalized therapy.

• Flicker-Free Delivery: Unlike stroboscopic light, our devices ensure comfort, enhancing adherence.

• Holistic Healing: Targets cellular, neural, and systemic health for Alzheimer’s, vision, and injury recovery.

• Safe and Accessible: FDA-cleared for pain and circulation, with off-label potential under medical supervision.

The Science Behind Our Devices

Research supports the efficacy of PBM and gamma entrainment:

• Alzheimer’s: 40 Hz stimulation reduces amyloid and tau, improves cognition (Cell, 2019; Neuron, 2019).

• Retinopathy/AMD: PBM protects retinal cells, improves visual function (Frontiers in Aging Neuroscience, 2023).

• Injuries: PEMF and PBM enhance neural and tissue repair (Journal of Neuroscience, 2020).

Human EEG studies (Herrmann, 2001; Bayram et al., 2011) confirm 40 Hz visual stimulation induces strong neural resonance, suggesting translatability to our devices. TrueRife and Seqex’s electromagnetic delivery further enhances deep tissue penetration, complementing Lumiceuticals’ light-based approach.

Patient Outcomes and Future Directions

At drjontz.com, patients using the “MED BED” package report:

• Improved memory and focus in early AD/MCI.

• Enhanced visual clarity in AMD/retinopathy.

• Faster recovery from TBIs and musculoskeletal injuries.

While human clinical trials are needed to confirm efficacy, preclinical data and our clinical observations are promising. We are committed to advancing research and integrating new findings to refine our protocols.

Getting Started

Our practice offers personalized consultations to explore how Lumiceuticals, TrueRife, and Seqex can support your health goals. Sessions last 20-40 minutes, with treatment plans tailored to Alzheimer’s, vision, or injury recovery. Contact me to schedule a consultation or learn more about my “MED BED” approach.

Conclusion

The integration of Lumiceuticals, TrueRife, and Seqex devices in my “MED BED” package represents a forward-thinking approach to brain health, vision, and injury recovery. By leveraging 40 Hz gamma entrainment and PBM, we aim to prevent and potentially reverse conditions like Alzheimer’s and retinopathy while supporting recovery from injuries. As research evolves, we remain dedicated to offering cutting-edge, non-invasive therapies at drjontz.com.

References:

• Carstensen et al., Mechanisms of Photobiomodulation Therapy XV, SPIE BiOS, 2020.

• Iaccarino et al., Nature, 2016.

• Martorell et al., Cell, 2019.

• Adaikkan et al., Neuron, 2019.

• Deng et al., Molecular Neurodegeneration, 2024.

• Herrmann, Experimental Brain Research, 2001.

• Bayram et al., Clinical EEG and Neuroscience, 2011.

• LumiCeuticals – Harmonic Light Therapy Systems.

• TrueRife – TrueFocus System.

• SEQEX ICR PEMF therapy

• Physical exercise during exposure to 40-Hz light flicker.

Disclaimer: This blog is for informational purposes only and does not constitute medical advice. Consult a healthcare professional before starting any new therapy.